DAVID PEYSER: Open Payments
NPI 1194075887 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 43 payments from 15 companies in 2025. Trend: 2023 $339 · 2024 $1,471 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $227 |
| ABBVIE INC. | 7 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $126 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| Lilly USA, LLC | 3 | $75 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Exact Sciences Corporation | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
Products named: Kerendia, Ozempic, QULIPTA, MOUNJARO, SHINGRIX, Rybelsus, Wegovy, Symbravo.
Industry payments across NJ — which companies pay providers there.
